Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Furong Investment, commonly referred to as Furong Capital, appears to be a Shanghai-based venture investment firm rather than an operating biotechnology, pharmaceutical, or healthcare company. Publicly available sources describe it as an investor active across multiple sectors in China, including healthcare, biotechnology, semiconductors, and other technology industries. It has participated in financing rounds for life sciences companies such as TYK Medicines and Juncell Therapeutics, but there is no evidence that it develops therapeutic products of its own. Based on the available information, it should be classified as a financial investor with exposure to healthcare rather than a health-focused drug developer or services company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Furong Investment.